Physician profile
Mher Vartivarian
NPI 1801117874
$11,355.19
in general payments reported to CMS, 2019-2025
45 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,519 · 2020: $1,199 · 2021: $591 · 2022: $1,467 · 2023: $1,455 · 2024: $2,609 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,021 · Travel and Lodging: $538 · Education: $20.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,021.03 |
| Travel and Lodging | $538.00 |
| Education | $20.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,042.90 | 2019-2025 | Pico, Renasys Go V2 Home, Collagenase Santyl |
| Osiris Therapeutics INC. | $776.25 | 2019 | |
| Paragon 28, INC. | $633.71 | 2019-2025 | Phantom Fibula Nail, Precision Mis Bunion, Portfolio |
| Voom Medical Devices, INC. | $538.00 | 2024 | Revcon |
| Treace Medical Concepts, INC. | $536.33 | 2022-2025 | |
| Stryker Corporation | $520.28 | 2023-2025 | Infinity, Prostep Mica, Ortholoc 2 Lapifuse |
| Orthofix Medical, INC. | $495.74 | 2024-2025 | Physio-Stim, Accelstim |
| Kerecis Limited | $361.99 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Nevro Corp. | $355.19 | 2022-2024 | Senza |
| Curonix LLC | $333.35 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Organogenesis INC. | $310.39 | 2020-2023 | Puraply |
| Alafair Biosciences, INC. | $272.21 | 2024 | Versawrap |
| Amgen INC. | $264.11 | 2019-2025 | Krystexxa |
| Medline Industries LP | $219.28 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.23 | 2020-2023 | Jardiance |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mher Vartivarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.